The global high intensity focused ultrasound market size is anticipated to reach USD 1.97 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 7.06% during the forecast period, 2024 to 2030. The increasing prevalence of cancer and other chronic diseases, coupled with the growing demand for non-invasive treatment options, is expected to drive market growth. In addition, advancements in high intensity focused ultrasound (HIFU) technology and increasing research activities are contributing to the market expansion.
The rise in cancer cases worldwide is a significant driver for the HIFU market. HIFU offers a non-invasive alternative to traditional cancer treatments, such as surgery and radiation therapy, leading to higher adoption rates. Continuous innovations in HIFU technology, including the integration of artificial intelligence and improved imaging techniques, are enhancing the efficacy and precision of treatments, thereby boosting market growth. Increasing preference for non-invasive procedures among patients due to reduced recovery times, lower risk of infections, and minimal hospital stays is expected to propel the HIFU market. Beyond oncology, HIFU is being explored for treating other conditions, such as uterine fibroids, neurological disorders, and cosmetic applications, opening new avenues for market growth.
Furthermore, as the global burden of chronic diseases, HIFU's role in providing a non-invasive treatment option is becoming crucial in managing these conditions, driving market demand. Patients and healthcare providers are increasingly favoring non-invasive treatments due to their numerous benefits, such as reduced pain, shorter recovery periods, and decreased healthcare costs. Ongoing advancements in HIFU technology, including the development of more precise and efficient ultrasound devices, are enhancing treatment outcomes and expanding the potential applications of HIFU.
Request a free sample copy or view report summary: High Intensity Focused Ultrasound Market Report
In 2023, the dermatology application segment dominated the market by capturing over 20% of the market share. This is primarily attributed to the increasing adoption of HIFU technology for various aesthetic and therapeutic applications.
Among the end use, hospitals held a majority revenue share of 39.9% in 2023. This is owing to the adoption of technologically advanced medical devices by hospitals.
North America dominated the global market with a share of over 39% in 2023. This can be attributed to the presence of key market players and ongoing research and development activities in the region.
Grand View Research has segmented the global high intensity focused ultrasound (HIFU) market report based on application, end-use, and region:
High Intensity Focused Ultrasound (HIFU) Application Outlook (Revenue, USD Million, 2018 - 2030)
Uterine Fibroids
Prostate Cancer
Essential Tremor
Dermatology
Breast Cancer
Glaucoma
Backpain, Facetogenic
Other Applications
High Intensity Focused Ultrasound (HIFU) End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Imaging Centers
Other End-users
High Intensity Focused Ultrasound (HIFU) Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the High Intensity Focused Ultrasound Market
Focal One
Sonablate Corp.
Verasonics, Inc.
ALPINION MEDICAL SYSTEMS Co., Ltd.
Theraclion
Chongqing Haifu Medical Technology Co., Ltd.
Lynton Lasers Ltd
ULTRAISER
Profound Medical Inc.
"The quality of research they have done for us has been excellent..."